Back to search
FDAFDA · Food and drugs·Recall number D-0494-2025

Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-1003-2

Published July 2, 2025 · Recall initiated: May 28, 2025

Summary

FDA records drug Class II recall D-0494-2025, published July 2, 2025 and initiated May 28, 2025. Recalling firm: Apotex Corp.; Status: Ongoing; Reported quantity: 87,840 bottles; Lot: Batch TZ1236, Exp Date: 11/30/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email if KETOROLAC TROMETHAMINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
KETOROLAC TROMETHAMINE
Manufacturer
Apotex Corp.
Distributor
US Nationwide.
Lot
Batch TZ1236, Exp Date: 11/30/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-1003-2 recalled?

Yes. FDA published recall D-0494-2025 on July 2, 2025. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: KETOROLAC TROMETHAMINE.